Literature DB >> 11503957

Differentiation, apoptosis, and function of human immature and mature myeloid cells: intracellular signaling mechanism.

Akira Yuo1.   

Abstract

Human myeloid cells include hematopoietic cells at various stages of differentiation, from immature myeloid cells to mature phagocytes. Normal immature myeloid cells undergo differentiation concomitantly with proliferation in response to hematopoietic growth factors, and terminally differentiated cells, ie, mature phagocytes, exert their effector functions and then die a natural death via apoptosis. However, leukemic myeloid cells are induced to differentiate with growth suppression by several inducers, such as retinoic acid. This review describes differentiation, apoptosis, and functionality of human myeloid cells. mainly focusing on the intracellular signaling mechanism. The signal transduction system for these biological events of the life cycle of myeloid cells has recently been studied, and several characteristics have been elucidated. First, the signaling pathway for myeloid differentiation is mainly focused in the mitogen-activated protein kinases, such as extracellular signal-regulated kinase and p38, and transcriptional factors such as the signal transducers and activators of transcription PU.1 and CCAAT enhancer binding protein. Second, the signaling mechanism for myeloid cell apoptosis is fundamentally identical to that found in other cells. Caspases, caspase-activated DNase, and mitochondrial molecules such as apoptosis-inducing factor have been reported to be important, and mitogen-activated protein kinases such as p38 appear to be less important. Finally, p38 and phosphatidylinositol 3-kinase play critical roles in the signaling cascade for functional activation of mature phagocytes. The reasons why the same signaling molecules play distinct roles according to the differentiation stage and biological event await future clarification.

Entities:  

Mesh:

Year:  2001        PMID: 11503957     DOI: 10.1007/BF02994005

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  160 in total

1.  The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase.

Authors:  F V Lali; A E Hunt; S J Turner; B M Foxwell
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

2.  Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells.

Authors:  K Shimozaki; K Nakajima; T Hirano; S Nagata
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

Review 3.  Hematopoietic regulators: redundancy or subtlety?

Authors:  D Metcalf
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

4.  Priming of the neutrophil respiratory burst involves p38 mitogen-activated protein kinase-dependent exocytosis of flavocytochrome b558-containing granules.

Authors:  R A Ward; M Nakamura; K R McLeish
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 5.  New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities.

Authors:  O Bruserud; B T Gjertsen
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

6.  Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis.

Authors:  Y Nagata; K Todokoro
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

7.  Activation of p90RSK and cAMP response element binding protein in stimulated neutrophils: novel effects of the pyridinyl imidazole SB 203580 on activation of the extracellular signal-regulated kinase cascade.

Authors:  J P Lian; R Huang; D Robinson; J A Badwey
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

8.  Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines.

Authors:  F Yanagisawa-Shiota; H Sakagami; N Kuribayashi; M Iida; T Sakagami; M Takeda
Journal:  Anticancer Res       Date:  1995 Mar-Apr       Impact factor: 2.480

Review 9.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release.

Authors:  S Kitagawa; A Yuo; M Yagisawa; E Azuma; M Yoshida; Y Furukawa; M Takahashi; J Masuyama; F Takaku
Journal:  Exp Hematol       Date:  1996-03       Impact factor: 3.084

View more
  5 in total

1.  Novel dichlorophenyl urea compounds inhibit proliferation of human leukemia HL-60 cells by inducing cell cycle arrest, differentiation and apoptosis.

Authors:  James L Figarola; Yehua Weng; Christopher Lincoln; David Horne; Samuel Rahbar
Journal:  Invest New Drugs       Date:  2011-07-05       Impact factor: 3.850

2.  Granulocyte colony-stimulating factor-induced terminal maturation of human myeloid cells is specifically associated with up-regulation of receptor-mediated function and CD10 expression.

Authors:  Yuko Inazawa; Kumiko Saeki; Akira Yuo
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

3.  Identification of human neutrophils during experimentally induced inflammation in mice with transplanted CD34+ cells from human umbilical cord blood.

Authors:  Masaru Doshi; Makoto Koyanagi; Masako Nakahara; Koichi Saeki; Kumiko Saeki; Akira Yuo
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

4.  Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.

Authors:  Koichi Saeki; Norihiko Kobayashi; Yuko Inazawa; Hong Zhang; Hideki Nishitoh; Hidenori Ichijo; Kumiko Saeki; Mamoru Isemura; Akira Yuo
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

5.  FAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity.

Authors:  Paulo Bentes de Carvalho-Neto; Marcelo dos Santos; Marcos Brasilino de Carvalho; Ana Maria da Cunha Mercante; Viviane Priscila Pina dos Santos; Patrícia Severino; Eloiza Helena Tajara; Iuri Drumond Louro; Adriana Madeira Álvares da Silva-Conforti
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.